APPLIKON BIOTECHNOLOGY HOLDING BV
Status: Completed investmentWhy disclosure?
FMO is committed to making publicly available relevant investment information that informs stakeholders and enables them to engage directly with FMO on its investments which, in turn, enhances our investment decisions, the design and implementation of projects and policies, and strengthens development outcomes. Learn more
In case of questions
In case of questions, please contact us at disclosure@fmo.nl
Disclaimer
The information as disclosed is indicative and provided on an "as-is/as available" basis for general informational purposes only and should not be construed as financial, legal or investment advice, nor as a commitment or an offer to arrange or provide any financing. The final decision to provide financing is subject to the terms and conditions of FMO in its sole and absolute discretion. When providing links to other sites, FMO bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. The information on proposed investment for high-risk investments is made available in the language relevant to the country or region where the bulk of operations take place. Translations of any information into languages other than English are intended as a convenience for local stakeholders. In case of any discrepancy, the information provided in English will prevail.
Who is our customer
Applikon Biotechnology was founded in the Netherlands in 1973 and today is a leading supplier of bioreactor control systems to the biopharma and laboratory markets. These systems are used in a variety of production and analytical processes ranging from vaccines to yeast production.
What is our funding objective?
Applikon Biotechnology will pursue a joint venture with its Chinese partner Abiocan to produce systems for the fast growing Chinese and broader Asian markets. FMO's financing will go towards the companies' joint investment in a modern production location in Guangzhou.
Why do we fund this investment?
Applikon is a high-tech small to medium-sized company. It will provide products which are currently not produced in the local market. FMO’s involvement has been highly additional as comparable local financing is not available for companies without a local track record. Applikon will contribute to skilled job creation.
- Region
- Asia
- Country
- China
- Sector
- Infrastructure, Manufacturing and Services
- Effective date
- 11/19/2012
- End date
- 1/21/2020
- Total FMO financing
- EUR 1.10 MLN
- Funding
- Fund Emerging Markets
-
Risk categorization on environmental and social impacts, A = high risk, B+ = medium high risk, B = medium risk, C = low risk
Environmental & Social Category
(A, B+, B or C) - B